“The keynote speakers last year discussed new and innovative approaches to treating the various types of breast cancer, as well as new prevention strategies. There were many fascinating advancements in care to learn about with our peers,” said Hadeel Assad, Hadeel Assad, M.D., medical oncologist and co-leader of the Breast Cancer Multidisciplinary Team (MDT), and co-chair of this year’s symposium. “We’re looking forward to hearing Drs. Hurvitz and Hewitt’s presentations and to learn about the groundbreaking work they are doing at their institutions and the care our colleagues are providing here at Karmanos and across the McLaren Health Care system.”
Lydia Choi, M.D., breast surgeon and member of the Breast Cancer MDT, is also co-chair of the 2025 symposium. Additional presenters from Karmanos’ Breast Cancer MDT and the McLaren Proton Therapy Center, part of the Karmanos Cancer Network, will present the following:
- “Updates in Management of HER2 Positive Breast Cancer” – Jalian Elayoubi, M.D., medical oncologist
- “Making the Case for Breast Reconstruction… or Not” – Guillermina Nava, M.D., breast reconstructive surgeon
- “Updates in ER+ and TNBC” – Lawrence Flaherty, M.D., medical oncologist
- “Updates in Breast Cancer Radiotherapy” – Brian Yeh, M.D., Ph.D., radiation oncologist
- “Women’s Wellness Clinic: Survivorship, High-Risk Screening” – Amy Legghio, MSN, CNP, OCN, nurse practitioner
Lubina Arjyal, M.D., medical oncologist, will lead a case presentation and panel discussion.
The cost to attend is $125 for physicians and pharmacists; $50 for mid-level providers, retired physicians and other allied health providers; $25 for nurses; and $20 for fellows, residents and medical students, which is refundable upon attendance.
The deadline to register is Thursday, April 10. Register online at karmanos.org/breastcancersymposium.
For additional information, contact Pamela Sydorchuk at 313-576-8746 or [email protected].